Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Relapsed/Refractory Acute Myeloid Leukaemia
Wuhan, Hubei
Relapsed/Refractory Acute Myeloid Leukaemia Clinical Trials in Wuhan, Hubei
1 recruiting
Wuhan, Hubei, China
Showing
1–1
of
1
trials
Recruiting
Phase 1
Phase 2
Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML
Myeloid Malignancy
Relapsed/Refractory Acute Myeloid Leukaemia
Ascentage Pharma Group Inc.
682 enrolled
12 locations
NCT04501120
Feedback